Wei Wang, PhD U.S. FDA

Wei Wang is a Microbiologist at Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), Office of Compliance and Biologics Quality (OCBQ), Division of Manufacturing and Product Quality (DMPQ). Wei has a B.A. and a M.A. in Engineering of Industrial Microbiology from South China Institute of Technology (SCIT, Guangzhou, China) and a Ph.D. in Biology from New York University (New York, NY).  Wei has performed regulatory review of different types of submissions, including Biologics License Applications (BLA) and various supplements, Investigative New Drug (INDs), and conducted pre-license inspections and pre-approval inspections in support of the review BLA and prior-approval supplements.